The movement of multidrug-resistant tuberculosis across borders in East Africa needs a regional and global solution

PLoS Med. 2015 Feb 24;12(2):e1001791. doi: 10.1371/journal.pmed.1001791. eCollection 2015 Feb.

Abstract

Kevin Cain and colleagues reflect on the cross border movement of people from Somalia with MDR-TB and the implications for MDR-TB programs in East Africa.

MeSH terms

  • Africa, Eastern / epidemiology
  • Antitubercular Agents*
  • Emigration and Immigration*
  • Epidemics*
  • Health Services Needs and Demand*
  • Humans
  • Mycobacterium tuberculosis*
  • Refugees
  • Somalia / epidemiology
  • Tuberculosis, Multidrug-Resistant* / epidemiology
  • Tuberculosis, Multidrug-Resistant* / microbiology
  • Tuberculosis, Multidrug-Resistant* / therapy
  • Tuberculosis, Pulmonary* / epidemiology
  • Tuberculosis, Pulmonary* / microbiology
  • Tuberculosis, Pulmonary* / therapy

Substances

  • Antitubercular Agents

Grants and funding

There was no funding source for this work other than the author's salaries, which were paid by our institutions. The views and opinions expressed in this article are those of the authors and do not necessarily represent an official position of the US Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.